CY1109267T1 - Μεθοδοι για την καλλιεργεια κυκλοϊου - Google Patents

Μεθοδοι για την καλλιεργεια κυκλοϊου

Info

Publication number
CY1109267T1
CY1109267T1 CY20091100822T CY091100822T CY1109267T1 CY 1109267 T1 CY1109267 T1 CY 1109267T1 CY 20091100822 T CY20091100822 T CY 20091100822T CY 091100822 T CY091100822 T CY 091100822T CY 1109267 T1 CY1109267 T1 CY 1109267T1
Authority
CY
Cyprus
Prior art keywords
methods
cultivation
cyclot
circoviruses
present
Prior art date
Application number
CY20091100822T
Other languages
English (en)
Inventor
Qiang Liu
Suresh K Tikoo
Philip Willson
Lorne A Babiuk
Original Assignee
University Of Saskatchewan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University Of Saskatchewan filed Critical University Of Saskatchewan
Publication of CY1109267T1 publication Critical patent/CY1109267T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/10011—Circoviridae
    • C12N2750/10021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/10011—Circoviridae
    • C12N2750/10041—Use of virus, viral particle or viral elements as a vector
    • C12N2750/10043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/10011—Circoviridae
    • C12N2750/10051—Methods of production or purification of viral material
    • C12N2750/10052—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Η παρούσα εφεύρεση σχετίζεται με μεθόδους για την καλλιέργεια κυκλοϊού και ειδικότερα δε, κυκλοϊού χοίρων. Η παρούσα εφεύρεση παρέχει συνθέσεις και μεθόδους για την καλλιέργεια κυκλοϊού χοίρων σε κύτταρα θηλαστικών που εκφράζουν την λειτουργία Ε1 του αδενοϊού των θηλαστικών.
CY20091100822T 2001-03-27 2009-08-04 Μεθοδοι για την καλλιεργεια κυκλοϊου CY1109267T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27917301P 2001-03-27 2001-03-27
EP02712700A EP1379671B1 (en) 2001-03-27 2002-03-27 Methods to culture circovirus

Publications (1)

Publication Number Publication Date
CY1109267T1 true CY1109267T1 (el) 2014-07-02

Family

ID=23067939

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20091100822T CY1109267T1 (el) 2001-03-27 2009-08-04 Μεθοδοι για την καλλιεργεια κυκλοϊου

Country Status (24)

Country Link
US (3) US6794163B2 (el)
EP (1) EP1379671B1 (el)
JP (1) JP4038127B2 (el)
KR (1) KR100876629B1 (el)
CN (2) CN1309836C (el)
AT (1) ATE430807T1 (el)
AU (1) AU2002244584B2 (el)
BR (1) BRPI0208456B8 (el)
CA (1) CA2442135C (el)
CY (1) CY1109267T1 (el)
CZ (1) CZ304525B6 (el)
DE (1) DE60232234D1 (el)
DK (1) DK1379671T3 (el)
ES (1) ES2324466T3 (el)
HU (1) HU228065B1 (el)
MX (1) MXPA03008810A (el)
MY (2) MY148759A (el)
PL (1) PL202951B1 (el)
PT (1) PT1379671E (el)
RU (2) RU2312142C2 (el)
SK (1) SK287969B6 (el)
UA (1) UA82647C2 (el)
WO (1) WO2002077210A2 (el)
ZA (1) ZA200307517B (el)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040062775A1 (en) * 1997-12-05 2004-04-01 Agence Francaise De Securite Sanitaire Des Aliments Circovirus sequences associated with piglet weight loss disease (PWD)
FR2772047B1 (fr) * 1997-12-05 2004-04-09 Ct Nat D Etudes Veterinaires E Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection
ES2170622B1 (es) * 1999-12-03 2004-05-16 Consejo Superior De Investigaciones Cientificas Clones y vectores infectivos derivados de coronavirus y sus aplicaciones.
MY148759A (en) * 2001-03-27 2013-05-31 Univ Saskatchewan Methods to culture circovirus
US20030096377A1 (en) * 2001-06-28 2003-05-22 Virginia Tech Intellectual Properties, Inc. Differential PCR-RFLP assay for detecting and distinguishing between nonpathogenic PCV-1 and pathogenic PCV-2
US7279166B2 (en) 2001-12-12 2007-10-09 Virginia Tech Intellectual Properties, Inc. Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
US7276353B2 (en) * 2001-12-12 2007-10-02 Virginia Tech Intellectual Properties, Inc. Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
UA95602C2 (ru) 2004-12-30 2011-08-25 Берингер Ингельхейм Ветмедика, Инк. Иммуногенная композиция цвс2 и способы приготовления такой композиции
US7700285B1 (en) 2005-12-29 2010-04-20 Boehringer Ingelheim Vetmedica, Inc. PCV2 immunogenic compositions and methods of producing such compositions
US7833707B2 (en) 2004-12-30 2010-11-16 Boehringer Ingelheim Vetmedica, Inc. Methods of overexpression and recovery of porcine circovirus type 2 ORF2
US8834891B2 (en) 2005-03-14 2014-09-16 Boehringer Ingelheim Vetmedica, Inc. Immunogenic compositions comprising Lawsonia intracellularis
PL1968630T3 (pl) 2005-12-29 2018-08-31 Boehringer Ingelheim Vetmedica, Inc. Multiwalentne immunogenne kompozycje PCV2
CN104383526B (zh) 2005-12-29 2018-09-18 贝林格尔.英格海姆维特梅迪卡有限公司 Pcv2免疫原性组合物用于减轻猪临床症状的用途
US20100129397A1 (en) * 2006-12-11 2010-05-27 Boehringer Ingelheim Vetmedica, Inc. Effective method of treatment of porcine circovirus and lawsonia intracellularis infections
EP2094872B2 (en) 2006-12-15 2020-02-19 Boehringer Ingelheim Animal Health USA Inc. Treatment of anti-PCV2 antibody seropositive pigs with PCV2 antigen
EP1941903A1 (en) 2007-01-03 2008-07-09 Boehringer Ingelheim Vetmedica Gmbh Prophylaxis and treatment of PRDC
EP1958644A1 (en) 2007-02-13 2008-08-20 Boehringer Ingelheim Vetmedica Gmbh Prevention and treatment of sub-clinical pcvd
CA2687146C (en) * 2007-05-11 2015-07-21 Temasek Life Sciences Laboratory Limited Production of a homogeneous cell line highly permissive to porcine circovirus type 2 (pcv2) infection
WO2008151215A1 (en) * 2007-06-04 2008-12-11 Merial Limited Production of porcine circovirus proteins in plants
US7829274B2 (en) 2007-09-04 2010-11-09 Boehringer Ingelheim Vetmedica, Inc. Reduction of concomitant infections in pigs by the use of PCV2 antigen
EP2225367A1 (en) * 2007-12-21 2010-09-08 Wyeth LLC Methods and compositions for immunizing pigs against porcine circovirus
US20110020394A1 (en) * 2007-12-31 2011-01-27 Boehringer Ingelheim Vetmedica, Inc. Pcv2 orf2 virus like particle with foreign amino acid insertion
EP2242511A4 (en) * 2008-01-23 2012-10-24 Boehringer Ingelheim Vetmed IMMUNOGENIC COMPOSITIONS OF MYCOPLASMA HYOPNEUMONIAE PCV2, AND METHODS FOR PRODUCING SUCH COMPOSITIONS
AU2009236669B2 (en) * 2008-04-16 2012-12-06 Virginia Tech Intellectual Properties, Inc. Chimeric porcine circovirus PCV2Gen-1Rep and uses thereof
AR078253A1 (es) * 2009-09-02 2011-10-26 Boehringer Ingelheim Vetmed Metodos para reducir la actividad antivirica en composiciones pcv-2 y composiciones pcv-2 con mejor inmunogenicidad
EP2528931A4 (en) * 2010-01-25 2013-12-04 Blood Systems Inc CYCLOVIRUS AND USE METHOD THEREFOR
JP6821429B2 (ja) 2013-09-25 2021-01-27 ゾエティス・サービシーズ・エルエルシー Ｐｃｖ２ｂ分岐ワクチン組成物及び使用方法
EA035265B1 (ru) 2013-10-02 2020-05-21 Бёрингер Ингельхайм Энимал Хелс Ю-Эс-Эй Инк. Вариант белка opc2 pcv2 и содержащие его вирусоподобные частицы
US9944904B2 (en) 2015-05-14 2018-04-17 Merial Inc. Method for porcine circovirus production and PCV2 vaccines
WO2018071511A1 (en) * 2016-10-11 2018-04-19 Orion Labs Group communication forwarding to a secondary service
CN114934020B (zh) * 2022-01-30 2024-02-13 山东省滨州畜牧兽医研究院 猪视网膜上皮细胞系及其建立方法和应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9712852A (pt) * 1996-10-23 1999-11-16 Univ Pennsylvania Plasmìdeo, composição, processo de imunização de um indivìduo contra um patógeno, vacina recombinante, patógeno vivo atenuado, proteìna bl-1 substancialmente pura, vetor recombinante de expressão, e, anticorpo isolado
AUPO856097A0 (en) 1997-08-14 1997-09-04 Commonwealth Scientific And Industrial Research Organisation Vector
US6391314B1 (en) 1997-10-03 2002-05-21 Merial Porcine circoviruses vaccines diagnostic reagents
FR2781159B1 (fr) 1998-07-06 2000-10-06 Merial Sas Vaccin circovirus et parvovirus porcin
UA78180C2 (uk) 1997-10-03 2007-03-15 Меріаль Кільцевий вірус свині типу ii, вакцини та діагностичні реагенти
US7192594B2 (en) 1997-10-03 2007-03-20 Merial Limited Postweaning multisystemic wasting syndrome and porcine circovirus from pigs
US6517843B1 (en) * 1999-08-31 2003-02-11 Merial Reduction of porcine circovirus-2 viral load with inactivated PCV-2
FR2772047B1 (fr) 1997-12-05 2004-04-09 Ct Nat D Etudes Veterinaires E Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection
WO1999045956A1 (en) 1998-03-13 1999-09-16 University Of Georgia Research Foundation, Inc. Vaccines against circovirus infections
US6492343B1 (en) 1998-04-15 2002-12-10 University Of Saskatchewan Porcine adenovirus type 3 genome
WO2000014092A1 (en) 1998-09-08 2000-03-16 Giri Brij P Chemiluminescent 1,2-dioxetanes
JP2002528128A (ja) 1998-11-02 2002-09-03 ユニバーシティ オブ サスカチュワン 組換えアデノウイルスベクターの増殖のためのアデノウイルス必須機能を発現するウシ細胞
FR2789695B1 (fr) 1999-02-11 2003-03-07 Merial Sas Vecteurs et vaccins viraux a base d'adenovirus porcins recombines et replicatifs
US6943152B1 (en) 1999-06-10 2005-09-13 Merial DNA vaccine-PCV
US6497883B1 (en) 1999-06-10 2002-12-24 Merial Porcine circovirus recombinant poxvirus vaccine
EP1311698A2 (en) * 2000-05-03 2003-05-21 University Of Guelph Porcine adenovirus type 5 vector and vaccine
MY148759A (en) * 2001-03-27 2013-05-31 Univ Saskatchewan Methods to culture circovirus

Also Published As

Publication number Publication date
PL364077A1 (en) 2004-12-13
KR20040002881A (ko) 2004-01-07
WO2002077210A3 (en) 2003-08-21
US20020177216A1 (en) 2002-11-28
US7560278B2 (en) 2009-07-14
US20050239187A1 (en) 2005-10-27
MY146518A (en) 2012-08-15
AU2002244584B2 (en) 2006-12-14
JP4038127B2 (ja) 2008-01-23
CN1625598A (zh) 2005-06-08
MY148759A (en) 2013-05-31
CN1840656A (zh) 2006-10-04
ATE430807T1 (de) 2009-05-15
UA82647C2 (uk) 2008-05-12
US6794163B2 (en) 2004-09-21
CA2442135C (en) 2008-08-19
RU2007110808A (ru) 2008-09-27
SK287969B6 (sk) 2012-08-06
US7172899B2 (en) 2007-02-06
DK1379671T3 (da) 2009-06-29
CN1840656B (zh) 2010-06-02
US20070128700A1 (en) 2007-06-07
BR0208456A (pt) 2004-03-02
WO2002077210A2 (en) 2002-10-03
EP1379671B1 (en) 2009-05-06
HUP0500161A2 (hu) 2005-05-30
JP2005500822A (ja) 2005-01-13
ES2324466T3 (es) 2009-08-07
RU2003131342A (ru) 2005-04-20
CZ20032584A3 (en) 2004-03-17
ZA200307517B (en) 2004-09-27
SK12102003A3 (sk) 2004-05-04
CA2442135A1 (en) 2002-10-03
RU2312142C2 (ru) 2007-12-10
CZ304525B6 (cs) 2014-06-18
KR100876629B1 (ko) 2009-01-07
DE60232234D1 (de) 2009-06-18
BRPI0208456B1 (pt) 2016-10-18
EP1379671A2 (en) 2004-01-14
CN1309836C (zh) 2007-04-11
MXPA03008810A (es) 2004-02-17
HUP0500161A3 (en) 2010-01-28
PT1379671E (pt) 2009-07-20
BRPI0208456B8 (pt) 2021-05-25
HU228065B1 (en) 2012-09-28
PL202951B1 (pl) 2009-08-31

Similar Documents

Publication Publication Date Title
CY1109267T1 (el) Μεθοδοι για την καλλιεργεια κυκλοϊου
NO20043259L (no) Bindingsproteiner som biosensorer
NO20043245L (no) Bindingsproteiner som biosensorer
ATE548391T1 (de) Gefangene bindungsproteine als biosensoren
DE60031419D1 (de) Zusammensetzungen und verfahren für verbesserte zellkultur
DK0922102T3 (da) Receptor-agonister af hepatocyt-vækstfaktor og anvendelser deraf
MA34209B1 (fr) Protéines à domaine de squelette basé sur la fibronectine qui se lient à pcsk9
EA200600065A3 (ru) Гидрофобные композиционные и сыпучие материалы, их применение
BRPI0518209A (pt) agentes de ligação especìficos à angiopoietina-2
BR0312764A (pt) Cardiomiócitos funcionais originados de células-tronco embrionárias humanas
CY1118101T1 (el) Φορεας κυτταρων που περιεχει κολλαγονο
WO2003052084A3 (fr) Construits cellulaires cultives in vitro, preparation et utilisations
EA200801385A1 (ru) Способ образования дендритных клеток с применением пониженной температуры
WO2007005659A3 (en) Methods and compositions for culturing keratinocytes
DE60039306D1 (de) Nonapeptidische ny-eso-1 derivate und deren verwendung
AU2003259750A1 (en) Methods and compositions for targeting secretory lysosomes
ATE357507T1 (de) Behandlung von menschlicher unfruchtbarkeit
ATE437846T1 (de) Cyclooct-(en-)yl-derivate zur verwendung als duftstoffe
ATE374243T1 (de) Knorpelzell-kulturmedium und verwendung desselben
TW200722520A (en) Human mensenchymal stem cells and culturing methods thereof
ATE449863T1 (de) Verwendung von lepa zur verbesserung der genauigkeit der in-vitro-proteinsynthese
EA200200804A1 (ru) Способ исследования панкреатического сока и способ определения изменения состава панкреатического сока
UA11184U (uk) Спосіб гасіння власної флуоресценції білків